Shengqi Shen

1.4k total citations
23 papers, 876 citations indexed

About

Shengqi Shen is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Shengqi Shen has authored 23 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Shengqi Shen's work include Cancer, Hypoxia, and Metabolism (7 papers), RNA modifications and cancer (7 papers) and Immune cells in cancer (5 papers). Shengqi Shen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), RNA modifications and cancer (7 papers) and Immune cells in cancer (5 papers). Shengqi Shen collaborates with scholars based in China, Poland and United States. Shengqi Shen's co-authors include Ping Gao, Huafeng Zhang, Linchong Sun, Weidong Jia, Caixia Suo, Gongwei Wu, Zhaoji Liu, Wenhao Ma, Xiaoping He and Ronghui Yan and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and The EMBO Journal.

In The Last Decade

Shengqi Shen

22 papers receiving 871 citations

Peers

Shengqi Shen
Danyu Du China
Shamir Cassim France
Lou Baudrier United States
Jianjun Liu China
Haijun Zhang China
Seon-Hyeong Lee South Korea
Maria Quiles del Rey United States
Yifeng Tian China
Macus Hao‐Ran Bao Hong Kong
Romain Riscal United States
Danyu Du China
Shengqi Shen
Citations per year, relative to Shengqi Shen Shengqi Shen (= 1×) peers Danyu Du

Countries citing papers authored by Shengqi Shen

Since Specialization
Citations

This map shows the geographic impact of Shengqi Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengqi Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengqi Shen more than expected).

Fields of papers citing papers by Shengqi Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengqi Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengqi Shen. The network helps show where Shengqi Shen may publish in the future.

Co-authorship network of co-authors of Shengqi Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Shengqi Shen. A scholar is included among the top collaborators of Shengqi Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengqi Shen. Shengqi Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Rui, Yuchen Sun, Shengqi Shen, et al.. (2025). High-throughput screening identifies a dual-activity inhibitor of OXCT1 for hepatocellular carcinoma therapy. Bioorganic Chemistry. 165. 108964–108964.
2.
Ye, Ling, Shengqi Shen, Hui Lü, et al.. (2025). Nuclear-localized HKDC1 promotes hepatocellular carcinoma through phosphorylating RBBP5 to upregulate H3K4me3. Cell Reports. 44(2). 115250–115250. 1 indexed citations
3.
Zhang, Yi, Mingjie Wang, Ling Ye, et al.. (2024). HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression. Nature Communications. 15(1). 1314–1314. 24 indexed citations
4.
Ma, Wenhao, Yuchen Sun, Ronghui Yan, et al.. (2024). OXCT1 functions as a succinyltransferase, contributing to hepatocellular carcinoma via succinylating LACTB. Molecular Cell. 84(3). 538–551.e7. 43 indexed citations
5.
Zhang, Yi, Shengqi Shen, Mingjie Wang, et al.. (2024). EPDR1 promotes PD-L1 expression and tumor immune evasion by inhibiting TRIM21-dependent ubiquitylation of IkappaB kinase-β. The EMBO Journal. 43(19). 4248–4273. 4 indexed citations
6.
Hao, Yijie, Zilong Zhou, Rui Liu, et al.. (2024). Mitochondria-localized MBD2c facilitates mtDNA transcription and drug resistance. Nature Chemical Biology. 21(6). 926–938. 5 indexed citations
7.
Yan, Ronghui, Shiting Li, Haiying Liu, et al.. (2024). PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression. Protein & Cell. 16(1). 49–63. 25 indexed citations
8.
Chen, Rui, Zhiyuan Lin, Shengqi Shen, et al.. (2024). Citrullination modulation stabilizes HIF-1α to promote tumour progression. Nature Communications. 15(1). 7654–7654. 11 indexed citations
9.
Yan, Ronghui, Shengqi Shen, Yu Zeng, et al.. (2024). Carnosine regulation of intracellular pH homeostasis promotes lysosome-dependent tumor immunoevasion. Nature Immunology. 25(3). 483–495. 28 indexed citations
10.
Yin, Qiyue, Shengqi Shen, Jun Yang, et al.. (2024). Distributed Deep Reinforcement Learning: A Survey and a Multi-player Multi-agent Learning Toolbox. 21(3). 411–430. 6 indexed citations
11.
Sun, Linchong, Caixia Suo, Tong Zhang, et al.. (2023). ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism. Nature Chemical Biology. 19(12). 1492–1503. 30 indexed citations
12.
Suo, Caixia, Haoran Wei, Xuemei Gu, et al.. (2022). Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5. Frontiers in Oncology. 12. 857968–857968. 18 indexed citations
13.
Liu, Zhaoji, Linchong Sun, Yongping Cai, et al.. (2021). Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1. Cancer Research. 81(5). 1265–1278. 42 indexed citations
14.
Wu, Gongwei, Caixia Suo, Ying Yang, et al.. (2021). MYC promotes cancer progression by modulating m 6 A modifications to suppress target gene translation. EMBO Reports. 22(3). e51519–e51519. 33 indexed citations
15.
Wang, Yinghui, Hui Lü, Linchong Sun, et al.. (2021). Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase. Cell Death and Disease. 12(10). 902–902. 13 indexed citations
16.
Zhang, Tong, Linchong Sun, Yijie Hao, et al.. (2021). ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nature Cancer. 3(1). 75–89. 138 indexed citations
17.
Xing, Songge, Zhaoyong Li, Wenhao Ma, et al.. (2019). DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing. Cancer Research. 79(19). 4923–4936. 38 indexed citations
18.
Cao, Yang, Shengqi Shen, Yongping Cai, et al.. (2019). Glycine cleavage system determines the fate of pluripotent stem cells via the regulation of senescence and epigenetic modifications. Life Science Alliance. 2(5). e201900413–e201900413. 20 indexed citations
19.
Wu, Gongwei, Shengqi Shen, Xiaoyu Ma, et al.. (2017). Menin enhances c-Myc-mediated transcription to promote cancer progression. Nature Communications. 8(1). 15278–15278. 46 indexed citations
20.
Sun, Linchong, Libing Song, Qianfen Wan, et al.. (2015). cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Research. 25(4). 429–444. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danyu Du Breakdown of academic impact, for papers by Shamir Cassim Breakdown of academic impact, for papers by Lou Baudrier Breakdown of academic impact, for papers by Jianjun Liu Breakdown of academic impact, for papers by Haijun Zhang Breakdown of academic impact, for papers by Seon-Hyeong Lee Breakdown of academic impact, for papers by Maria Quiles del Rey Breakdown of academic impact, for papers by Yifeng Tian Breakdown of academic impact, for papers by Macus Hao‐Ran Bao Breakdown of academic impact, for papers by Romain Riscal
Rankless by CCL
2026